Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328599 · ClinicalTrials.gov registry record
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes
A clinical trial, sponsored by Ali Aminian.
- Completed
- Registry status
- 262
- Enrollment target
NCT02328599 is a clinical trial that has completed, run by Ali Aminian. The registered enrollment target is 262 participants.
The verdict
NCT02328599 has completed, sponsored by Ali Aminian.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
Study Summary
Initially, 4 teams of investigators conducted randomized controlled trials (RCT) at their own site to evaluate the effectiveness of bariatric surgery compared to medical/lifestyle management of type 2 diabetes. Each study followed subjects for a duration of about 1 - 3 years. Following this, a consortium was created to pool data and continue to follow study participants. This early collaboration of the 4 groups of investigators was supported by Industry sponsors (Ethicon, Inc and Medtronic-MITG). Now, the investigators have successfully received a grant from the NIH, as the sole supporter of continued observational follow-up of study participants. The continuing aim of this study is to combine data from the 4 studies and follow the original randomized subjects for an additional 5 years of follow-up. The purpose of the study is to determine the longer term durability and effectiveness of bariatric surgery compared to medical/lifestyle intervention on the treatment of type 2 diabetes.
Interventions
- PROCEDURE Bariatric surgery involving Roux-en-Y gastric bypass
- PROCEDURE Bariatric surgery involving Laparoscopic adjustable gastric banding
- PROCEDURE Bariatric surgery involving Laparoscopic sleeve gastrectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2024-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02328599
The ClinicalTrials.gov registry entry for NCT02328599 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ali Aminian, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bariatric surgery involving Roux-en-Y gastric bypass is the first listed.
NCT02328599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02328599 about?
NCT02328599 is a clinical study titled "Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes". Initially, 4 teams of investigators conducted randomized controlled trials (RCT) at their own site to evaluate the effectiveness of bariatric surgery compared to medical/lifestyle management of type 2 diabetes. Each study followed subjects for a duration of about 1 - 3 years. Following this, a conso...
What is the current status of trial NCT02328599?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2018-04-10. Estimated completion is 2024-02-27.
What interventions are being tested in trial NCT02328599?
The interventions under investigation include: Bariatric surgery involving Roux-en-Y gastric bypass (PROCEDURE), Bariatric surgery involving Laparoscopic adjustable gastric banding (PROCEDURE), Bariatric surgery involving Laparoscopic sleeve gastrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02328599?
This trial is sponsored by Ali Aminian, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.